Serina Therapeutics Inc (SER) — Cash Flow Quality Index
Serina Therapeutics Inc (SER) has a Cash Flow Quality Index of -2.14x as of September 2024. Operating cash flow of $-2.96 Million is below net income of $1.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SER operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Serina Therapeutics Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Serina Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SER cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Serina Therapeutics Inc (2023–2023)
Year-by-year earnings quality comparison for Serina Therapeutics Inc. For live market cap and the full company financial profile, see Serina Therapeutics Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.47x | $-2.48 Million | $5.27 Million | — |